Holdings
Great Point Partners LLC
As of Sep 30, 2026, Great Point Partners LLC reported 37 positions worth US$343M. Largest: Vera Therapeutics, Inc., Vor Biopharma Inc. and Amylyx Pharmaceuticals, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Vera Therapeutics, Inc. | 809K | US$26.1M | +208K | Sep 30, 2026 |
| Vor Biopharma Inc. | 1.13M | US$21.5M | −573K | Sep 30, 2026 |
| Amylyx Pharmaceuticals, Inc. | 700K | US$20.4M | no change | Sep 30, 2026 |
| Sagimet Biosciences Inc. - Series A | 1.96M | US$19.4M | −68,232 | Sep 30, 2026 |
| Definium Therapeutics, Inc. | 509K | US$19.4M | +83,735 | Sep 30, 2026 |
| Ionis Pharmaceuticals, Inc. | 420K | US$18.8M | new | Sep 30, 2026 |
| Genmab A/S | 525K | US$18.7M | new | Sep 30, 2026 |
| Zura Bio Limited | 4.08M | US$17M | −139K | Sep 30, 2026 |
| LB Pharmaceuticals Inc | 410K | US$15.8M | +93,199 | Sep 30, 2026 |
| Abivax SA | 155K | US$15.3M | −49,314 | Sep 30, 2026 |